Overview:Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
We are driven by innovation, and believe that investment in strong science and the relentless pursuit of R&D excellence can translate into new innovations that can positively impact patients’ lives.
Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across two franchises: Oncology and Inflammation & Autoimmunity.
Headquartered in Wilmington, Delaware, Incyte has operations in the U.S., Europe and Japan. Our more than 1,400 employees are led by distinguished executives with proven records of success.
We are proud to have been recognized by Forbes as one of the World’s Most Innovative Companies for each of the past four years. In 2018 and 2019, Incyte was also named a Top Employer by Science Magazine.
For more information about Incyte, please visit our corporate website at www.incyte.com and follow us on Twitter: www.twitter.com/incyte. See our Community Guidelines: http://bit.ly/2sV0H5W